文献速递眼整形与眼眶眼底病与葡萄膜炎

改良治疗阶梯算法联合球后两性霉素B用于侵袭性真菌性鼻眶窦炎

Outcomes of a Modified Treatment Ladder Algorithm Using Retrobulbar Amphotericin B for Invasive Fungal Rhino-Orbital Sinusitis.
PubMed 文献 · Am J Ophthalmol · 2021-06-09

单中心回顾性对照研究纳入50例活检证实的侵袭性真菌性鼻窦炎伴眼眶受累患者,2015年后引入经皮球后注射两性霉素B(TRAMB)作为改良治疗阶梯算法的一部分。

核心结论

  • 与历史对照相比,采用包含TRAMB的改良治疗阶梯算法治疗侵袭性真菌性鼻眶窦炎可降低毁容性眶内容物剜除的风险,且未明显增加死亡风险。

研究设计与样本

  • 回顾性、比较性临床研究,采用历史对照和准实验前后对照设计,纳入1999-2020年单中心连续50例活检证实的侵袭性真菌性鼻窦炎伴影像学眼眶受累患者。
  • 以2015年为界分为pre-2015组和post-2015组,比较人口学、免疫缺陷、感染病原体、眼科检查、手术治疗和生存情况。

主要发现

  • 两组基线特征无显著差异;几乎所有患者均接受手术干预,最常见为功能性内镜鼻窦手术加清创。
  • post-2015组中72.7%接受了TRAMB治疗。

临床怎么用

  • 对于活检证实的侵袭性真菌性鼻眶窦炎伴眼眶受累患者,可在治疗阶梯算法中纳入经皮球后注射两性霉素B,以降低眶内容物剜除风险。
  • 该策略在本研究中未显示增加死亡风险,但需结合患者个体情况和多学科协作决策。

局限性

  • 回顾性研究设计,采用历史对照,可能存在时间偏倚和未测量混杂因素。
  • 单中心研究,样本量50例,结果外推需谨慎。
  • TRAMB并非post-2015组所有患者均接受(72.7%),存在选择偏倚可能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To assess whether a modified treatment ladder algorithm incorporating transcutaneous retrobulbar amphotericin B (TRAMB) for invasive fungal rhino-orbital sinusitis can reduce the risk of exenteration without compromising survival. DESIGN: Retrospective, comparative clinical study with historical control subjects. METHODS: Fifty consecutive patients with biopsy-proven invasive fungal sinusitis and radiographic evidence of orbital involvement were evaluated at a single tertiary institution from 1999-2020. TRAMB was incorporated as part of the treatment algorithm in 2015. Demographics, underlying immune derangement, infective organism, ophthalmic examination, surgical care, and survival were compared in a quasiexperimental pre-post format, dividing patients into a pre-2015 group and a post-2015 group. Risk of exenteration and mortality were the primary outcomes. RESULTS: Baseline characteristics did not differ significantly between the 2 groups. Nearly all patients underwent a surgical intervention, most commonly functional endoscopic sinus surgery with debridement. TRAMB was administered to 72.7% of the post-2015 group. Exenteration was more common in the pre-2015 group (36.4% vs 9.1% [95% confidence interval {CI} 5.2-48.8]; P = .014), while mortality was similar (40.0% vs 36.7% [95% CI -22.1 to 29.3]; P = .816). After adjusting for potential confounders, patients treated after 2015 were found to have lower risk of exenteration (relative risk 0.28 [95% CI 0.08-0.99]; P = .049) and similar risk of mortality (relative risk 1.04 [95% CI 0.50-2.16]; P = .919). CONCLUSION: Compared with historical control subjects, patients with invasive fungal rhino-orbital sinusitis who were treated with a modified treatment ladder algorithm incorporating TRAMB had a lower risk of disfiguring exenteration without an apparent increase in the risk of mortality.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Ashraf DC, Idowu OO, Hirabayashi KE, et al. Outcomes of a Modified Treatment Ladder Algorithm Using Retrobulbar Amphotericin B for Invasive Fungal Rhino-Orbital Sinusitis. Am J Ophthalmol. 2021. PMID: 34116011. doi:10.1016/j.ajo.2021.05.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。